Managed care

ViiV Healthcare receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection

Retrieved on: 
Wednesday, July 3, 2019
Managed care, Research, Pharmaceutical, Infectious diseases, Science, Clinical trials, Biotechnology, AIDS, Health, HIV, Lentiviruses, ViiV Healthcare, Medical specialties, Articles, Health, Abacavir/dolutegravir/lamivudine

Dovato strengthens ViiV Healthcares industry-leading portfolio of innovative treatment approaches for people living with HIV.

Key Points: 
  • Dovato strengthens ViiV Healthcares industry-leading portfolio of innovative treatment approaches for people living with HIV.
  • Marketing Authorisation for Dovato is supported by data from the landmark global GEMINI 1 and 2 studies that included more than 1,400 HIV-1 infected adults.
  • Chief Scientific and Medical Officer, ViiV Healthcare said: The Marketing Authorisation of Dovato in Europe marks a significant development for people living with HIV.
  • This step is essential in the HIV replication cycle and is also responsible for establishing chronic infection.

Invacare Corporation Announces Enhanced Transformation Plan Progress Update

Retrieved on: 
Tuesday, July 2, 2019
Physical therapy, Medical devices, Managed care, General Health, Hospitals, Other Retail, Biotechnology, Other Manufacturing, Health, Manufacturing, Retail, Other Health, Invacare, IVC, International Video Corporation, Brantly, Economy of the United States

Invacare Corporation (NYSE: IVC) (Invacare or the company) is pleased to provide an update on its enhanced transformation and growth plan in three key areas: commercial effectiveness, product innovation, and simplifying business and an optimizing cost.

Key Points: 
  • Invacare Corporation (NYSE: IVC) (Invacare or the company) is pleased to provide an update on its enhanced transformation and growth plan in three key areas: commercial effectiveness, product innovation, and simplifying business and an optimizing cost.
  • Mr. Brantly re-joins Invacare from Amoena USA, where he served as Vice President of Sales.
  • Reflecting on these initiatives, Matthew E. Monaghan, chairman, president and chief executive officer commented, We continue to make progress against our enhanced transformation and growth plan, and I am confident that todays announcements, in conjunction with our ongoing strategic changes, will position Invacare for long-term success.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.

The Neuroscience of Autism: New Clues for How the Condition Begins

Retrieved on: 
Tuesday, July 2, 2019
Mental health, Managed care, Genetics, Science, Clinical trials, Biotechnology, Health, Other Science, Research, University, Education, Other Health, Glial cells, Developmental neuroscience, Branches of biology, Neuroscience, Cerebral cortex, Radial glial cell, Glia, RGC

View the full release here: https://www.businesswire.com/news/home/20190702005626/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190702005626/en/
    In green, a normal radial glial cell and its neuronal progeny superimposed in a cortex scaffold illustration.
  • Each RGC sprouts a single stalk-like structure, called a basal process that extends to the top of the cortex.
  • Mutations in the Memo1 gene also have been found in some people with autism and are suspected of causing the condition.
  • More than half of the schools 1,700 faculty members served as principal investigators on active research awards in 2018.

MAXIMUS Joins Statewide Project to Help Homeless with Disabilities in Minnesota

Retrieved on: 
Tuesday, July 2, 2019
Technology, Health, Insurance, Consumer, Professional services, Practice Management, Software, Managed care, General Health, Other Consumer, Homelessness, Housing, Humanitarian aid, Poverty, Socioeconomics, Disability, Minnesota, Humans, Academic disciplines, Culture

MAXIMUS, a leading provider of government services worldwide, announced today it joined a team of vendors selected to help Minnesotans with long-term disabilities, who are also homeless or at risk of becoming homeless, apply for Social Security disability benefits.

Key Points: 
  • MAXIMUS, a leading provider of government services worldwide, announced today it joined a team of vendors selected to help Minnesotans with long-term disabilities, who are also homeless or at risk of becoming homeless, apply for Social Security disability benefits.
  • The statewide contract with the Minnesota Department of Human Services (DHS) focuses on the Twin Cities metro area and has a duration of three years.
  • DHSs objectives in partnering with MAXIMUS to provide SOAR services are three-fold:
    Operations for the MAXIMUS-operated Minnesota SOAR Advocacy Project will be located in our already-established office in St. Paul.
  • The homeless are an especially vulnerable population, said Laura Rosenak, MAXIMUS Senior Vice President.

UnitedHealthcare and Optum Take Action to Support People Affected by Severe Weather and Flooding in West Virginia

Retrieved on: 
Tuesday, July 2, 2019
Pharmaceutical, Insurance, Managed care, Health, Hospitals, Professional services, Articles, Optum, Health, UnitedHealth Group, UNH, Mental health, Psychological stress, Companies

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by severe weather and flooding across parts of West Virginia.

Key Points: 
  • UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by severe weather and flooding across parts of West Virginia.
  • For plan participants who may have misplaced their medical ID cards, call 866-633-2446, 8 a.m.-8 p.m. (in the local time zone), Monday through Friday.
  • Free Help Line: Optum, a leading health and behavioral health services company, is offering a free emotional-support help line.
  • Specially trained Optum mental health specialists help people manage their stress and anxiety so they can continue to address their everyday needs.

US Osteoarthritis Market and Competitive Landscape, 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 2, 2019
Managed care, Pharmaceutical, Health, RTT, Skeletal disorders, Medical specialties, Medicine, Arthritis, Health, Osteoarthritis

The "US Osteoarthritis Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Osteoarthritis Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
  • The latest research, US Osteoarthritis Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Osteoarthritis pipeline products, Osteoarthritis epidemiology, Osteoarthritis market valuations and forecast, Osteoarthritis drugs sales and competitive landscape in the US.
  • Osteoarthritis pipeline: Find out the products in clinical trials for the treatment of Osteoarthritis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Osteoarthritis drugs: Identify key products marketed and prescribed for Osteoarthritis in the US, including trade name, molecule name, and company
    Osteoarthritis market valuations: Find out the market size for Osteoarthritis drugs in 2018 in the US.
  • Find out how the market advanced from 2014 and forecast to 2024
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Osteoarthritis products

US Allergic Rhinitis Market and Competitive Landscape, 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 2, 2019
Managed care, Pharmaceutical, Health, Medical specialties, Immunology, Medicine, Allergology, RTT, Rhinitis, Allergic rhinitis, Allergy

The "US Allergic Rhinitis Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Allergic Rhinitis Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
  • The latest research, US Allergic Rhinitis Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Allergic Rhinitis pipeline products, Allergic Rhinitis epidemiology, Allergic Rhinitis market valuations and forecast, Allergic Rhinitis drugs sales and competitive landscape in the US.
  • Allergic Rhinitis pipeline: Find out the products in clinical trials for the treatment of Allergic Rhinitis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Allergic Rhinitis drugs: Identify key products marketed and prescribed for Allergic Rhinitis in the US, including trade name, molecule name, and company
    Allergic Rhinitis market valuations: Find out the market size for Allergic Rhinitis drugs in 2018 in the US.
  • Find out how the market advanced from 2014 and forecast to 2024
    Allergic Rhinitis drugs market share: Find out the market shares for key Allergic Rhinitis drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Allergic Rhinitis products

UnitedHealth Group Announces Atlanta HBCU Partnership, $8.25 Million Investment in the Education of Future Data Scientists

Retrieved on: 
Tuesday, July 2, 2019
Technology, Managed care, Professional services, Hospitals, African-American, Consumer, Health, Continuing, University, Education, Insurance, Data management, UnitedHealth Group, Morehouse College, Spelman College, Morehouse, Organizations, Companies, United States

The five-year, $8.25 million investment by UnitedHealth Group is part of an ambitious collaboration with AUCC and its membership: Clark Atlanta University, Morehouse College, Morehouse School of Medicine and Spelman College.

Key Points: 
  • The five-year, $8.25 million investment by UnitedHealth Group is part of an ambitious collaboration with AUCC and its membership: Clark Atlanta University, Morehouse College, Morehouse School of Medicine and Spelman College.
  • The UnitedHealth Group funding will help to establish the base for this broad initiative, including hiring an accomplished director.
  • Technology in general, and data science in particular, are critical to better meeting the needs of our customers, said David S. Wichmann, CEO of UnitedHealth Group.
  • Since 2007, UnitedHealth Group has invested more than $20 million to fund nearly 2,600 scholarships for students pursuing careers as primary health care providers.

Premier’s ProvideGx™ Program to Make the First FDA-Approved Version of Cysteine Hydrochloride Available to Providers

Retrieved on: 
Tuesday, July 2, 2019
Mental health, FDA, Clinical trials, Managed care, Pharmaceutical, General Health, Health, Health, Organic compounds, Thiols, Pharmaceutical industry, Food and Drug Administration, United States Public Health Service, Injection, Cysteine, New Drug Application

(NASDAQ: PINC), through its ProvideGx program, is now supplying cysteine hydrochloride injection to providers, a critical drug for pediatric and adult patients that require total parenteral nutrition (TPN).

Key Points: 
  • (NASDAQ: PINC), through its ProvideGx program, is now supplying cysteine hydrochloride injection to providers, a critical drug for pediatric and adult patients that require total parenteral nutrition (TPN).
  • This FDA-approved New Drug Application (NDA) for cysteine hydrochloride injection is held by Exela Pharma Sciences, LLC, a U.S.-based manufacturer.
  • Current supplies of cysteine hydrochloride injection are imported from Canada under special FDA rules that allow shortage drugs to be sourced abroad if no domestic supplies are available.
  • This partnership is expected to allow Premier members to have uninterrupted access to the only domestic, FDA-approved version of cysteine hydrochloride injection a first in the industry, said Premiers President, Michael J. Alkire.

Ascension Saint Thomas Partners with Contessa to Bring Hospital-Level Care to Homes

Retrieved on: 
Tuesday, July 2, 2019
Technology, Nursing, Hospitals, Telecommunications, Managed care, General Health, Health, Health, Articles, Ascension, Hospital, Ascension Saint Thomas, Contessa

Ascension Saint Thomas and Nashville-based Contessa have announced a partnership to offer patients Home Recovery Care, an emerging healthcare option that brings all the essential elements of inpatient care to the comfort and convenience of patients homes.

Key Points: 
  • Ascension Saint Thomas and Nashville-based Contessa have announced a partnership to offer patients Home Recovery Care, an emerging healthcare option that brings all the essential elements of inpatient care to the comfort and convenience of patients homes.
  • As a Nashville-based company, we are especially thrilled to bring Home Recovery Care to Ascension Saint Thomas with a strong reputation across Tennessee and beyond, said Travis Messina, Chief Executive Officer, Contessa.
  • Ascension Saint Thomas continues to expand access to care with thoughtful offerings aligned with the needs of communities we serve, said Dr. Greg James, Chief Clinical Officer, Ascension Saint Thomas.
  • Home Recovery Care will be available for patients at Saint Thomas Midtown and West hospitals this fall, followed by Saint Thomas Rutherford and surrounding communities.